Fundraising Fox
/People
Sign in

Alfred Scheidegger

Investor

General Partner at Nextech Carry SCSP · General Partner at NEXTECH ONCOLOGY SCSP · General Partner at NEXTECH CROSSOVER SCSP · General Partner at Nextech Crossover Carry SCSp · Managing Partner at Nextech Invest · +1 more

Zurich

Writes $100K – $5M checks · typically $1.5M

Find your path to Alfred

295 people in our graph can introduce you to Alfred.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Kenneth Galbraith to introduce you to Alfred

You →Kenneth · together at TRACON Pharmaceuticals (2012–2014) →Alfred

Ask Jamie Chen to introduce you to Alfred

You →Jamie · 9 people · together at Nextech Invest Ltd. →Alfred

Ask Sam Okafor to introduce you to Alfred

You →Sam · 2 people · together at Venture →Alfred

Sign up to find every way you can get introduced to Alfred

  • Your email: the people you already email who know Alfred
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Alfred
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Alfred Scheidegger is co-founder and chairman of Lipovectra Inc. He founded and scaled an international venture capital firm and has served as CEO, chairman, and board member across numerous international companies focused on high-growth and innovation sectors including technology, pharma, and biotech. Scheidegger has experience in capital raising, corporate strategy, and operational leadership across Europe, Asia, and the United States, and is fluent in German and English with proficiency in Italian, Japanese, and French.

Board director at Cleave Biosciences

Intro paths

→

In turn, Alfred can intro founders to Cleave Biosciences's investors below.

Cleave Biosciences's investors · 9

5AM VenturesSan Francisco · $100K – $4M checksAstellas Venture Management LLCSouth San Francisco · $200K – $5M checksClarus VenturesMenlo ParkNew Enterprise Associates (NEA)Menlo Park · $200K – $40M checksNextech InvestZurich · $648K – $3.2M checks · since 2016OrbiMedNew York · $1M – $75M checksOsage University PartnersBala CynwydOUP (Osage University Partners)Bala Cynwyd · $1M – $20M checksUS Venture PartnersMenlo Park · $500K – $10M checks

Experience

  1. Lipovectra Inc.Co-Founder, Chairman of the Board of Directorcurrent2025 — present
  2. BioNeex UGMember of the Advisory Boardcurrent2024 — present
  3. KeliomicsAdvisor2024 — 2026Портленд, OR
  4. Wemedoo AGChairman of the Board of Directors2023 — 2026
  5. Nextech Invest Ltd.Founder, Managing Partner, Member of the Board of Directors1998 — 2025Zurich, Switzerland
  6. Dottikon Exclusive Synthesis AGVice Chairman of the Board of Directors2011 — 2024Dottikon, Switzerland
  7. Kura Kura International Ltd.Senior Advisor2021 — 2022Singapore
  8. Rising Tide Foundation GroupMember of the Foundation Board2017 — 2021Schaffhausen, Switzerland
  9. Cleave Biosciences, Inc.Member of the Board Of Directors2016 — 2019Burlingame, USA
  10. MolecularMDObserver of the Board of Directors2012 — 2016Portland, OR, USA
  11. Palyon Medical CorporationMember of the Board of Directors2009 — 2015Санта-Моника, CA
  12. TRACON PharmaceuticalsMember of the Board of Directors2012 — 2015San Diego, CA, USA
  13. Tetralogic PharmaceuticalsObserver of the Board of Directors2012 — 2013Malvern, PA, USA
  14. MacroGenics, Inc.Observer of the Board of Directors2012 — 2013Rockville, MD, USA
  15. The Genetics CompanyChairman of the Board of Directors2003 — 2013Zürich, Schweiz
  16. ImVisioN Therapeutics Inc.Observer of the Board of Directors2008 — 2012Muttenz, Basel-Landschaft, Schweiz
  17. Ganymed Pharmaceuticals AGMember of the Board of Directors2006 — 2008Mainz, Germany
  18. Agensys, Inc.Observer of the Board of Directors2007Santa Monica, CA, USA
  19. >>venture>> | Companies for tomorrowCo-Founder, Member of the Project Team, Member of the Jury1997 — 2007Zurich, Switzerland
  20. BioVision AGMember of the Supervisory Board2003 — 2005Hannover, Niedersachsen, Deutschland
  21. ETH ZurichAdministrative Director, Member of the Board1995 — 1998Zurich, Switzerland
  22. CSCS Swiss National Supercomputing CenterChief Executive Officer1992 — 1995Manno, TI, Switzerland
  23. International Science Club of Osaka, JapanDelegate of Ciba Geigy (Japan) Ltd. (today Novartis)1990 — 1991Osaka, Japan
  24. Industrial Science and Technology, Swiss Chamber of Commerce and Industry in JapanCo-Founder and Chairman of the Committee1990 — 1991Tokyo, Japan
  25. Ciba Geigy (Japan) Ltd. (today Novartis)Project Leader Drug Discovery1987 — 1991Basel, Switzerland and Takarazuka, Japan

Skills & more

Venture Capital2BiotechnologyCorporate DevelopmentLifesciencesCommercializationTechnology TransferStart-ups9Mergers & AcquisitionsM&A experiencePrivate Equity3IPOClinical Development
+12 moreDue DiligenceMedical DevicesGrowth CapitalBusiness StrategyStrategyValuationVenture FinancingPharmaceutical IndustryRisikokapitalPharmaindustriePrivates EigenkapitalFusionen und Übernahmen

Languages English · French · German · Italian · Japanese

From Alfred's professional profile.

Deals · 1

Cleave BiosciencesBoard seat

via Nextech Invest · filed Aug 2016 · $36.8M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Nextech Carry SCSP

Costas Constantinides
General Partner at Nextech Carry SCSP
Ian Charoub
General Partner at Nextech Carry SCSP
Jacob Loven
General Partner at Nextech Carry SCSP
Jakob Henrik Loven
General Partner at Nextech Carry SCSP
Rocco Sgobbo
General Partner at Nextech Partners SCSp
Thilo Schroeder
General Partner at Nextech Partners SCSp

Network1

Thilo Schroeder
General Partner at Nextech Partners SCSp

Investors connected to Alfred in public investor directories — a warm-intro map.

Frequently asked questions

Who is Alfred Scheidegger?
Alfred Scheidegger is co-founder and chairman of Lipovectra Inc. He founded and scaled an international venture capital firm and has served as CEO, chairman, and board member across numerous international companies focused on high-growth and innovation sectors including technology, pharma, and biotech. Scheidegger has experience in capital raising, corporate strategy, and operational leadership across Europe, Asia, and the United States, and is fluent in German and English with proficiency in Italian, Japanese, and French.
Where does Alfred Scheidegger work?
Alfred Scheidegger is General Partner at Nextech Carry SCSP and Board director at Cleave Biosciences.
What check size does Alfred Scheidegger write?
Alfred Scheidegger typically writes checks of $100K – $5M.
What boards does Alfred Scheidegger sit on?
Alfred Scheidegger holds tracked board seats at Cleave Biosciences.
Where did Alfred Scheidegger go to school?
Alfred Scheidegger studied at Harvard Business School (The General Manager, Business Administration and Management); Kyoto University (Postdoc in Enzymology); Biozentrum, University of Basel (Doctor of Philosophy (PhD), Biochemistry and Microbiology).

Same school

Shared employers